| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,397 |
18,441 |
$7.32M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,435 |
6,883 |
$4.26M |
| 54161 |
|
961 |
902 |
$2.55M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,198 |
2,713 |
$2.25M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
636 |
600 |
$1.80M |
| G0378 |
Hospital observation service, per hour |
6,256 |
3,904 |
$1.80M |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
775 |
723 |
$1.41M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,794 |
1,669 |
$1.22M |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,140 |
1,067 |
$1.17M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
1,950 |
1,809 |
$1.17M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,604 |
1,544 |
$439K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,948 |
1,840 |
$415K |
| 93320 |
|
1,900 |
1,764 |
$406K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
176 |
168 |
$351K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
5,054 |
1,631 |
$311K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,120 |
4,782 |
$263K |
| 93325 |
|
2,116 |
1,962 |
$174K |
| 42830 |
|
47 |
47 |
$152K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
61 |
61 |
$97K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
4,840 |
4,202 |
$86K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
214 |
205 |
$83K |
| 97162 |
|
229 |
221 |
$80K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
75 |
66 |
$75K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,514 |
3,218 |
$67K |
| 87631 |
|
458 |
428 |
$67K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
82 |
79 |
$66K |
| J2704 |
Injection, propofol, 10 mg |
3,915 |
3,593 |
$62K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,496 |
3,144 |
$56K |
| 00920 |
|
1,310 |
1,213 |
$54K |
| 92526 |
|
289 |
146 |
$53K |
| 69610 |
|
12 |
12 |
$51K |
| 71046 |
Radiologic examination, chest; 2 views |
2,847 |
2,688 |
$46K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
1,727 |
1,597 |
$42K |
| 80053 |
Comprehensive metabolic panel |
2,949 |
2,485 |
$40K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
209 |
94 |
$36K |
| 93304 |
|
43 |
43 |
$35K |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
990 |
944 |
$34K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
375 |
309 |
$34K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
193 |
142 |
$33K |
| 36415 |
Collection of venous blood by venipuncture |
2,232 |
1,863 |
$31K |
| 86900 |
|
15 |
13 |
$27K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,584 |
4,267 |
$25K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
25 |
24 |
$24K |
| 97161 |
|
86 |
82 |
$22K |
| 92523 |
|
90 |
89 |
$20K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
356 |
154 |
$18K |
| 76770 |
|
112 |
109 |
$18K |
| 87430 |
|
1,647 |
1,540 |
$17K |
| 97166 |
|
49 |
48 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,974 |
1,719 |
$16K |
| 92610 |
|
46 |
43 |
$15K |
| 93321 |
|
64 |
63 |
$14K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
991 |
898 |
$14K |
| 49452 |
|
17 |
16 |
$12K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
32 |
30 |
$12K |
| 00635 |
|
13 |
12 |
$11K |
| 93975 |
|
23 |
22 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
187 |
181 |
$8K |
| 87040 |
|
352 |
323 |
$7K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
32 |
31 |
$7K |
| 87088 |
|
845 |
774 |
$7K |
| 74240 |
|
47 |
45 |
$7K |
| 74019 |
|
510 |
484 |
$6K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
463 |
402 |
$6K |
| 97165 |
|
23 |
21 |
$6K |
| 87070 |
|
356 |
334 |
$6K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
212 |
204 |
$5K |
| 70450 |
Computed tomography, head or brain; without contrast material |
162 |
155 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,018 |
685 |
$5K |
| 97755 |
|
13 |
12 |
$4K |
| 86140 |
|
541 |
484 |
$4K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
417 |
414 |
$4K |
| 81001 |
|
704 |
650 |
$4K |
| 97542 |
|
58 |
48 |
$4K |
| 84145 |
|
169 |
154 |
$3K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
240 |
206 |
$3K |
| 85027 |
|
321 |
300 |
$2K |
| 00126 |
|
218 |
210 |
$2K |
| 81002 |
|
247 |
238 |
$2K |
| 74018 |
|
143 |
130 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
379 |
143 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
74 |
72 |
$2K |
| 87081 |
|
603 |
583 |
$2K |
| 96409 |
|
21 |
13 |
$2K |
| 72141 |
|
25 |
24 |
$1K |
| 74230 |
|
30 |
26 |
$1K |
| C1889 |
Implantable/insertable device, not otherwise classified |
42 |
41 |
$1K |
| 82248 |
|
37 |
28 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
27 |
26 |
$1K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
118 |
115 |
$908.04 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
210 |
165 |
$859.99 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
257 |
241 |
$809.56 |
| 96376 |
|
46 |
29 |
$697.71 |
| 00300 |
|
14 |
13 |
$627.02 |
| 73560 |
|
18 |
16 |
$620.82 |
| 81003 |
|
142 |
136 |
$539.91 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
123 |
116 |
$520.28 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
148 |
144 |
$497.09 |
| 92587 |
|
19 |
13 |
$475.26 |
| 76010 |
|
14 |
13 |
$396.33 |
| 85652 |
|
327 |
302 |
$363.82 |
| A9573 |
Injection, gadopiclenol, 1 ml |
15 |
13 |
$281.92 |
| 73130 |
|
27 |
25 |
$273.42 |
| 85730 |
|
117 |
106 |
$267.14 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
278 |
268 |
$241.15 |
| A6257 |
Transparent film, sterile, 16 sq. in. or less, each dressing |
55 |
47 |
$213.40 |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
14 |
13 |
$146.75 |
| 85007 |
|
312 |
290 |
$144.69 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
60 |
42 |
$144.69 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
102 |
93 |
$101.28 |
| 84100 |
|
143 |
134 |
$96.46 |
| 81025 |
|
189 |
176 |
$96.46 |
| 85610 |
|
119 |
109 |
$96.46 |
| 83735 |
|
133 |
127 |
$96.46 |
| 87077 |
|
82 |
79 |
$96.46 |
| 73590 |
|
14 |
12 |
$86.39 |
| 80305 |
|
92 |
89 |
$48.23 |
| 87186 |
|
74 |
71 |
$48.23 |
| 76937 |
|
13 |
12 |
$48.23 |
| 71045 |
Radiologic examination, chest; single view |
279 |
265 |
$48.23 |
| 82962 |
|
130 |
112 |
$48.23 |
| 82550 |
|
30 |
27 |
$48.23 |
| 82150 |
|
78 |
75 |
$48.23 |
| 83690 |
|
173 |
161 |
$48.23 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
117 |
109 |
$48.23 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
24 |
21 |
$48.23 |
| 89051 |
|
18 |
17 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
93 |
77 |
$0.00 |
| 85046 |
|
64 |
55 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
121 |
109 |
$0.00 |
| 87045 |
|
67 |
62 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
55 |
54 |
$0.00 |
| 82247 |
|
13 |
12 |
$0.00 |
| 00840 |
|
13 |
13 |
$0.00 |
| L8613 |
Ossicula implant |
59 |
59 |
$0.00 |
| 00731 |
|
20 |
20 |
$0.00 |
| 69210 |
|
13 |
13 |
$0.00 |
| 84439 |
|
32 |
30 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
122 |
120 |
$0.00 |
| 73610 |
|
14 |
13 |
$0.00 |
| 76376 |
|
20 |
20 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
28 |
13 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
15 |
13 |
$0.00 |
| 93308 |
|
14 |
14 |
$0.00 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
14 |
14 |
$0.00 |
| J9370 |
Vincristine sulfate, 1 mg |
19 |
14 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
199 |
164 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
40 |
40 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
14 |
14 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
115 |
113 |
$0.00 |
| 95700 |
|
61 |
59 |
$0.00 |
| 01922 |
|
19 |
19 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
32 |
31 |
$0.00 |
| C1769 |
Guide wire |
39 |
35 |
$0.00 |
| 74022 |
|
56 |
55 |
$0.00 |
| B4088 |
Gastrostomy/jejunostomy tube, low-profile, any material, any type, each |
18 |
16 |
$0.00 |
| 86850 |
|
12 |
12 |
$0.00 |
| 73090 |
|
54 |
44 |
$0.00 |
| 84484 |
|
18 |
18 |
$0.00 |
| 88108 |
|
14 |
13 |
$0.00 |
| 87205 |
|
41 |
38 |
$0.00 |
| 83605 |
|
13 |
12 |
$0.00 |
| 00120 |
|
15 |
15 |
$0.00 |
| 83880 |
|
12 |
12 |
$0.00 |
| 86901 |
|
15 |
13 |
$0.00 |